Neuroscience News and Research

RSS

Genetic risk for ADHD contributes to language, attention deficits in general population

Are deficits in attention limited to those with attention-deficit/hyperactivity disorder (ADHD) or is there a spectrum of attention function in the general population?

17 Oct 2014

Medical school applicants anxious about new MCAT

One of the biggest hurdles that college students face if they want to go to medical school is the MCAT - the Medical College Admission Test. The one-day standardized multiple-choice exam, which takes more than five hours to complete, is required for admission to nearly all medical schools in the United States. According to the Association of American Medical Colleges, more than 85,000 students take the MCAT each year.

16 Oct 2014

Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.

16 Oct 2014

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience. The Montréal scientists discovered that a protein found in the retina plays an essential role in the function and survival of light-sensing cells that are required for vision.

16 Oct 2014

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers from the University of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson's.

16 Oct 2014

Researchers define the process of Parkinson's disease using genetic mouse model

Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells.

16 Oct 2014

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Across the country, billions of dollars and millions of hours are spent on studying the inner workings of the brain as scientists search for ways to treat debilitating diseases and injuries such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury. Now, with the tremendous growth in basic knowledge driven by these efforts, researchers see a need to integrate their work across the broad scientific disciplines represented in modern neuroscience.

16 Oct 2014

NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

The New York Stem Cell Foundation today named six of the most promising scientists as its 2014 NYSCF – Robertson Investigators.

15 Oct 2014

MU research finds that neurons actively 'fine tune' for electrical imbalances at genetic level

Neurons are electrically charged cells, located in the nervous system, that interpret and transmit information using electrical and chemical signals. Now, researchers at the University of Missouri have determined that individual neurons can react differently to electrical signals at the molecular level and in different ways—even among neurons of the same type.

15 Oct 2014

Carnegie Mellon and Pitt to recognize Mark Roth with 2014 Friend of the CNBC Award

Mark Roth, an award-winning senior staff writer at the Pittsburgh Post-Gazette, will receive the 2014 Friend of the Center for the Neural Basis of Cognition Award from Carnegie Mellon University and the University of Pittsburgh.

15 Oct 2014

Research findings point toward new therapeutic target for aggressive breast cancer

One of the first-known oncogenes has a protein partner that helps breast cancer proliferate and when it's blocked, so is the cancer, scientists report.

15 Oct 2014

Scientists receive BBSRC funding to study how neural stem cells differ from each other

A team of scientists led by a researcher from Plymouth University has received funding of more than £400,000 from the Biotechnology and Biological Sciences Research Council to investigate how neural stem cells differ from each other. The study's findings could hold the key to the future use of neural stem cells in treatments to eradicate neurological conditions such as dementia and brain tumours.

15 Oct 2014

UCLA's new collaborative research effort aims to support adolescents, young adults with autism

UCLA, renowned for its leadership in research and treatment for individuals with autism, is launching a first-of-its-kind collaborative research effort to address the health, family and social needs of adolescents and young adults with autism, a group typically overlooked by health care and social services systems.

14 Oct 2014

LaVision BioTec report on users of light sheet microscopy in the Miami Project to Cure Paralysis

LaVison BioTec, developers of advanced microscopy solutions for the life sciences, report on users of their Ultramicroscope Light Sheet Fluorescence Microscope system to aid the research of the Miami Project to Cure Paralysis under the supervision of Professor Vance Lemmon, the Walter G. Ross Distinguished Chair in Developmental Neuroscience & Professor of Neurological Surgery at the University of Miami.

14 Oct 2014

New guideline makes recommendations about treating, managing distal muscular dystrophy

A new guideline from the American Association of Neuromuscular & Electrodiagnostic Medicine and the American Academy of Neurology recommends guidance on how doctors should evaluate the full picture—from symptoms, family history, and ethnicity, to a physical exam and certain lab test results—in order to determine what genetic tests may best diagnose a person's subtype of limb-girdle or distal muscular dystrophy.

14 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

Multi-center study compares clinical performance of AAA procedures in virtual environment

University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians.

13 Oct 2014

Neuroscience News and Research

Genetic risk for ADHD contributes to language, attention deficits in general population

Medical school applicants anxious about new MCAT

Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers define the process of Parkinson's disease using genetic mouse model

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

MU research finds that neurons actively 'fine tune' for electrical imbalances at genetic level

Carnegie Mellon and Pitt to recognize Mark Roth with 2014 Friend of the CNBC Award

Research findings point toward new therapeutic target for aggressive breast cancer

Scientists receive BBSRC funding to study how neural stem cells differ from each other

UCLA's new collaborative research effort aims to support adolescents, young adults with autism

LaVision BioTec report on users of light sheet microscopy in the Miami Project to Cure Paralysis

New guideline makes recommendations about treating, managing distal muscular dystrophy

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Multi-center study compares clinical performance of AAA procedures in virtual environment

New UCLA study reveals why people with autism experience neural stem cell overgrowth after birth

BIDMC scientists uncover new class of molecules that protects against diabetes

USC to become a hub for exploring the human brain

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News